![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Sun Pharma to acquire Japan’s Pola Pharma through arm
Sun Pharmaceutical Industries, through one of its wholly owned subsidiaries, is set to acquire Pola...
Indian biosimilar market to be worth $40 billion by 2030
The Confederation of Indian Industry (CII) & Sathguru Management Consultants released a position paper on...
Record year for pharma packaging and drug delivery innovation’ says Pharmapack
In an all-time record year for FDA approvals (48 so far in 2018), Pharmapack Europe...
Record growth at The Wasdell Group
The Wasdell Group , a leading outsourcing partner for the pharmaceutical, medical device and clinical...
Bormioli Pharma to sell its borosilicate glass tubing business
Bormioli Pharma S.p.A. announced that Corning Pharmaceutical Glass S.p.A., a wholly-owned subsidiary of Corning Incorporated,...
Omya acquires Galderma-Spirig site
Following Galderma-Spirig’s decision to close their Egerkingen site in September 2017, Omya International, based in...
Europe’s bio capacity forecast to overtake the USA by 2022 according to CPhI Annual...
Bio capacity in Europe is predicted to overtake the USA by 2020 according to the...
CPhI Annual report forecasts CMOs to benefit from double digit approvals for ADCs in...
The global ADC therapeutics market is expected to grow to $4bn by 2023, with double...
CPhI Annual Report warns pharma manufacturers that don’t invest in continuous manufacturing will be...
CPhI Worldwide, the world’s largest pharma event – taking place in Madrid (9-11, October 2018)...
CPhI Annual Report expert warns innovation is being hindered by regulators
CPhI Worldwide the world’s largest pharma event – taking place in Madrid October (9-11) and...